Question 47

Venlafaxine extended-release (Effexor XR) is used to treat depression.

Venlafaxine extended-release (Effexor XR) is primarily prescribed for the treatment of major depressive disorder. It works as a serotonin-norepinephrine reuptake inhibitor (SNRI), helping to alleviate symptoms of depression.

A) Ulcers

Venlafaxine is not indicated for the treatment of ulcers. Ulcers are typically treated with medications such as proton pump inhibitors or H2-receptor antagonists, which target stomach acid production rather than the neurotransmitter systems affected by venlafaxine.

B) Hypertension

While venlafaxine can potentially raise blood pressure at higher doses, it is not prescribed for the treatment of hypertension. The primary use of venlafaxine is to manage depression and anxiety disorders, rather than as an antihypertensive medication.

C) Depression

Venlafaxine extended-release (Effexor XR) is specifically indicated for the treatment of major depressive disorder. It effectively increases serotonin and norepinephrine levels in the brain, which are crucial in regulating mood and emotional balance.

D) Asthma

Venlafaxine is not used to treat asthma. Asthma management typically involves bronchodilators and anti-inflammatory medications, which do not include antidepressants like venlafaxine.

Conclusion

The correct answer is C, as venlafaxine extended-release (Effexor XR) is specifically designed to treat depression through its effects on neurotransmitter levels. All other options are incorrect as they pertain to conditions that venlafaxine does not target, highlighting its specific role in mental health rather than in gastrointestinal, cardiovascular, or respiratory disorders.